Long restricted by the federal government and stigmatized by the medical and scientific communities, cannabis has been involved in only a handful of studies carried out in the United States over the past several decades.
The goal of a cannabis research study doesn’t always have to be the creation of a drug approved by the U.S. Food and Drug Administration.
Six entities are registered with the DEA to cultivate marijuana for DEA-licensed researchers working on studies approved by the FDA.
CT Pharma earned FDA approval to grow cannabis for Yale University, which is exploring the efficacy of cannabis to treat stress and pain.
Guy Rocourt, the CEO of Papa & Barkley, a California-based infused products maker, has followed cannabis research from his earliest days in the legal marijuana industry.
As the company’s former chief operating officer, Rocourt infused what he learned into the balms, edibles, tinctures and other products Papa & Barkley produces.
Oklahoma regulators are accusing a testing lab of reporting passing results for dozens of contaminated medical marijuana products, leading to a recall affecting 33 cultivation and processing businesses.
Colorado regulators expanded a product recall for marijuana flower produced by a vertically integrated business in Boulder.
New York increased the number of conditional adult-use marijuana cultivation licensees from 88 to 146 after the state’s Cannabis Control Board approved 58 new applications.
The number of medical marijuana storefronts in Ohio could soon more than double after the state’s pharmacy board approved 70 provisional dispensary licenses.
A venture capital investment vehicle owned by the state of Connecticut has invested $1.25 million in the marijuana edibles company 1906.
The regulated cannabis industry promised to right the wrongs of the war on drugs, but white males still hold disproportionate numbers of C-suite positions.
The battle for social equity in cannabis, as in every other industry, includes achieving pay equity.
Generally speaking, pay equity means employees get paid the same amount for substantially similar work.
